62.2 F
Fort Worth
Thursday, November 26, 2020
Health Care Galderma now shipping new topical rosacea treatment

Galderma now shipping new topical rosacea treatment

Other News

Exxon’s oil slick

Exxon Mobil is slashing its capital spending budget for 2020 by 30% due to weak demand caused by the COVID-19 pandemic and a market...

Folk music’s Mark Twain: 7 Essential tracks from John Prine,

NEW YORK (AP) — Some people, the songs just come out of them. For nearly half a century, they tumbled out of John Prine...

Tarrant County records another COVID-19 death

Tarrant County Public Health (TCPH) on Wednesday, April 8 reported that a resident of Euless has died as the result of the COVID-19 virus....

Tradition stymied: A year unlike any since WWII for Augusta

The Masters is so intertwined with Augusta, they added an extra day to spring break.You see, the first full week of April isn't just...
Robert Francis
Robert is a Fort Worth native and longtime editor of the Fort Worth Business Press. He is a former president of the local Society of Professional Journalists and was a freelancer for a variety of newspapers, weeklies and magazines, including American Way, BrandWeek and InformatonWeek. A graduate of TCU, Robert has held a variety of writing and editing positions at publications such as the Grand Prairie Daily News and InfoWorld. He is also a musician and playwright.

By Carolyn Poirot 

Fort Worth Business Press Health Correspondent 

cpoirot@bizpress.net

A local company is now selling what is said to be the first-ever topical gel created specifically to combat the facial erythema (redness) of rosacea. The U.S. Food and Drug Administration approved Mirvaso topical gel, developed by Galderma Laboratories L.P. in late August, and the product reached most pharmacies around the country earlier this month, a company spokesman said Thursday. The product is available by prescription. 

“This milestone exemplifies Galderma’s continued, two-decade-long commitment to R&D to address the unmet needs of rosacea patients and clinicians,” said Francois Fournier, president of North American Operations for Galderma Laboratories, headquartered in Fort Worth. “Mirvaso Gel marks a turning point in rosacea treatment. Mirvaso is going to fill a great vacuum in the armamentarium of products to address the daily stress and anxiety caused by the persistent facial redness of rosacea – providing patients with an effective topical therapy,” Fournier said.

An estimated 16 million Americans are affected by rosacea, a chronic inflammatory and vascular disorder characterized by redness, visible blood vessels, bumps and blemishes on the forehead, nose and cheeks, according to the National Rosacea Society. Dealing with erythema – the most common symptom of rosacea – every day can be embarrassing and cause anxiety and frustration, a survey from the Rosacea Society found. Some 76 percent of people with the disorder say rosacea’s effect on their facial appearance lowered their self-confidence and self-esteem. Although the cause of rosacea is unknown, common triggers include sun exposure, emotional stress, hot or cold weather, heavy exercise, alcohol, spicy foods, heated beverages, humidity and certain skin-care products, the Rosacea Society says on its website. Patients should use the medication as directed by their physicians, but Mirvaso Gel can be used daily to reduce the persistent redness of rosacea, a company spokesman said. Pea-size amounts are applied to each of the five regions of the face: the forehead, chin, nose and each cheek.

More than 45 million people worldwide have symptoms of the disorder, the Rosacea Research & Development Institute says. Among the most famous rosacea sufferers is former President Bill Clinton, whose diagnosis was reported in the New York Times. Others have included comedian W.C. Fields, Princess Diana, financier J.P. Morgan and the Dutch painter Rembrant, according to the Rosacea Society. Interest in the new prescription gel that works within 30 minutes of application and lasts up to 12 hours, has been high, and Galderma has been actively meeting with managed care companies working to ensure that patients have access to this first-in-class therapeutic option, a company spokesman said.

Galderma is committed to research and development of new products in dermatology, and several other new medical solutions addressing major dermatological needs will be launched in the next years, Fournier said. “An innovation such as Mirvaso Gel is a strong example of Galderma’s continuous commitment to investing in skin research and delivering innovative medical solutions to address unmet dermatological needs,” he said. “Galderma has chosen to invest each year approximately 20 percent of its global revenues in research and development.”  


close






Oh hi there 👋
It’s nice to meet you.

Sign up to receive awesome content in your inbox.

We don’t spam! Read our privacy policy for more info.

Latest News

3rd major COVID-19 vaccine shown to be effective and cheaper

By DANICA KIRKA Associated PressLONDON (AP) — Drugmaker AstraZeneca said Monday that late-stage trials showed its COVID-19 vaccine is highly effective, buoying the prospects...

These health care workers will be first in line for a COVID-19 vaccine

Health care workers will be the first people in Texas to receive a COVID-19 vaccine once one receives emergency approval from the U.S. government,...

Tarrant County reports 1,537 new COVID cases on Sunday and 6 deaths

Tarrant County Public Health reported 1,537 new cases on Sunday, Nov. 22 and six deaths. “It took 90 days to reach 10,000 cases in June....

Employers start sending workers shopping for health coverage

Instead of offering one or more options, some companies are turning health insurance shopping over to employees. A federal rule change last year stoked this...

Abbott appoints Michael Coble to Texas Forensic Science Commission

Gov. Greg Abbott has appointed Michael Coble, Ph.D. to the Texas Forensic Science Commission for a term set to expire on Sept. 1, 2021. The...